Status of antibiotic use in hospitalized children with community-acquired pneumonia in multiple regions of China

• Published in: Zhongguo dang dai er ke za zhi 2019-01, Vol.21 (1), p.11
• Main Authors: Wei, Wei, Wang, Xue-Feng, Liu, Jian-Ping, Shen, Kun-Ling, Ma, Rong, Cui, Zhen-Ze, Deng, Li, Li, Yan-Ning, Jiang, Zhi-Yan, Xu, Hua, Wang, Li-Ning, Feng, Xiao-Chun, Wu, Zhen-Qi, Liu, Zhao-Lan, Huang, Yan, He, Chun-Hui, Liu, Hua, Zhao, Xue, Wang, Zi, Hao, Ou-Mei
• Format: Article
• Language: Chinese
• Subjects: Anti-Bacterial Agents - therapeutic use; Child; Child, Hospitalized; China; Community-Acquired Infections - drug therapy; Humans
• ISSN: 1008-8830

To investigate the use of antibiotics in children with community-acquired pneumonia (CAP) in multiple regions of China, and to provide a reference for CAP standard treatment and rational antibiotic use in children. The medical data of 1 383 children with CAP who were hospitalized in the department of pediatrics in 10 grade A tertiary hospitals from 9 cities between April 14, 2014 and January 1, 2016 were reviewed, to analyze the status of antibiotic use in hospitalized children in North China, Northeast China, East China, and South China. The overall rate of antibiotic use in children with CAP was 89.08%, with 88.7% in North China, 95.5% in Northeast China, 83.3% in East China, and 86.6% in South China. The main types of antibiotics used were cephalosporins, macrolides, compound preparations of β-lactam antibiotics, polyphosphoric broad-spectrum antibiotics and other β-lactam antibiotics. The selection of antibiotics was generally rational, but antibiotics were still used in some patients with viral infection